Abstract
Aims: Since sunitinib is effective in metastatic renal cancer and GIST tumors, we evaluated tolerability and efficacy of sunitinib for the first time in highly pretreated caucasian patients (pts) with unresectable metastatic (met.) adenocarcinoma of stomach, esophagogastric junction or lower oesophagus.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
